Otonomy to Participate in Three Upcoming Investor Conferences

Back to Jobs

SAN DIEGO , Feb. 25, 2021 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management will participate in three upcoming virtual conferences: A fireside chat at the Cowen 41st

Apply Now